小鼠胚胎远端气道干细胞的优化衍生-猫眼课题宝

小鼠胚胎远端气道干细胞的优化衍生

批准号：

8680325

负责人：

CHRISTINE M FINCK

金额：

$33.69万

依托单位：

UNIVERSITY OF CONNECTICUT SCH OF MED/DNT

依托单位国家：

美国

项目类别：

财政年份：

2010

资助国家：

美国

项目状态：

已结题

起止时间：

2010-07-01 至 2016-06-30

来源：

https://reporter.nih.gov/project-details/8680325

关键词：

3-Dimensional Accounting Air Sacs Alveolar Applications Grants Biomimetics Birth Blood Vessels Blood capillaries Cell Differentiation process Cells Childhood Coculture Techniques Cues Derivation procedure Development Discipline of obstetrics Distal Embryo Endoderm Endoderm Cell Endothelial Cells Environment Epithelial Epithelial Cells Event FGF2 gene Fibroblast Growth Factor 2 Gases Goals Grant Growth Factor Hydrogels In Vitro Laboratories Low Birth Weight Infant Lung Lung diseases Mesenchymal Methods Mus Neonatal Nodal Pathologic Processes Pathway interactions Perinatal mortality demographics Premature Birth Process Production Proteins Pulmonary Mass Pulmonary Pathology Research Personnel Serum Stem cells Structure of parenchyma of lung Supplementation Surgeon Time Tissue Engineering Training Transplantation Undifferentiated United States activin A alveolar epithelium capillary embryonic stem cell fetal improved in vivo innovation novel premature lungs scaffold small molecule stem cell therapy surfactant three dimensional structure transcription factor

项目摘要

项目成果

CHRISTINE M FINCK的其他基金

相似基金

相关文献

中文摘要

翻译

描述（由申请人提供）：肺发育不全（PH）的病理包括肺体积减少，由于缺乏表面活性剂蛋白产生而导致肺保持扩张的能力不足，气囊衬里（肺泡上皮）分化差，气体交换减少。我们的长期目标是通过干细胞治疗，利用体外干细胞衍生的远端气道细胞来增加早产儿肺组织，以减轻新生儿PH。具体的假设是，通过提供转录和生长因子来重现关键的发育事件，将优化远端气道细胞的衍生。这包括一个两步的过程，从最终的内胚层衍生到分化为远端气道细胞。此外，提供三维支架将通过提供重要的空间线索来提高远端气道细胞的产量。在肺中，远端气道的发育和完整对于适当的气体交换、表面活性剂的产生和生存至关重要。本课题的重点是探索从胚胎干细胞中提取远端气道细胞的方法。我们的具体目标包括：1：优化小鼠胚胎干细胞最终内胚层细胞的衍生，特别是通过操纵Wnt和结通路或通过提供小分子。2：通过补充生长因子，特别是fgf2,7,10，优化远端气道细胞的衍生。3：在时间允许的情况下，利用具有体内移植潜力的三维水凝胶支架优化空间线索。

英文摘要

DESCRIPTION (provided by applicant): The pathology of Pulmonary Hypoplasia (PH) includes reduced lung mass, insufficient ability of the lungs to stay expanded due to a deficiency in surfactant protein production, a poorly differentiated lining of the air sac (alveolar epithelium), and a reduction of gas exchange. Our long term goal is to alleviate neonatal PH using stem cell therapy to augment premature lung tissue with in vitro stem cell derived distal airway cells. The specific hypothesis is that recapitulation of key developmental events by providing transcription and growth factors will optimize derivation of distal airway cells. This includes a 2 step process with derivation of definitive endoderm followed by differentiation into distal airway cells. Furthermore, providing a 3-dimensional scaffold will enhance our yield of distal airway cells by providing important spatial cues. In the lung, distal airway development and integrity is essential for proper gas exchange, surfactant production and survival. The focus of this grant proposal is to explore methods of deriving distal airway cells from embryonic stem cells. Our specific aims include: 1: Optimize derivation of definitive endoderm cells from murine embryonic stem cells, specifically by manipulating the Wnt and nodal pathway or by providing small molecules. 2: Optimize derivation of distal airway cells through growth factor supplementation, specifically FGF2, 7,10. 3: Optimize spatial cues utilizing 3-dimensional hydrogel scaffolds with potential transplantation in vivo, time permitting.

期刊论文(7)

专著(0)

科研奖励(0)

会议论文